Patents by Inventor Daniel van Kammen

Daniel van Kammen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS
    Publication number: 20150231126
    Abstract: Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown induce a rapid onset of antipsychotic action and increase the responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic.
    Type: Application
    Filed: May 1, 2015
    Publication date: August 20, 2015
    Inventors: Perry Peters, David Furlano, Daun Bahr, Daniel Van Kammen, Mark Brann
  • Combination of pimavanserin and risperidone for the treatment of psychosis
    Patent number: 9050343
    Abstract: Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown to induce a rapid onset of antipsychotic action and increase the number of responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: June 9, 2015
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Perry Peters, David Furlano, Daun Bahr, Daniel Van Kammen
  • COMBINATION OF PIMAVANSERIN AND RISPERIDONE FOR THE TREATMENT OF PSYCHOSIS
    Publication number: 20130143901
    Abstract: Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown to induce a rapid onset of antipsychotic action and increase the number of responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic.
    Type: Application
    Filed: January 30, 2013
    Publication date: June 6, 2013
    Applicant: Acadia Pharmaceuticals, Inc.
    Inventors: Perry PETERS, David FURLANO, Daun BAHR, Daniel VAN KAMMEN, Mark BRANN
  • COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS
    Publication number: 20090053329
    Abstract: Combinations of 5-HT2A inverse agonists or antagonists such as pimavanserin with antipsychotics such as risperidone are shown to induce a rapid onset of antipsychotic action and increase the number of responders when compared to therapy with the antipsychotic alone. These effects can be achieved at a low dose of the antipsychotic, thereby reducing the incidence of side effects. The combinations are also effective at decreases the incidence of weight gain and increased glucose or prolactin levels caused by the antipsychotic.
    Type: Application
    Filed: March 19, 2008
    Publication date: February 26, 2009
    Applicant: Acadia Pharmaceuticals, Inc.
    Inventors: Perry Peters, David Furlano, Daun Bahr, Daniel Van Kammen, Mark Brann
  • USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS
    Publication number: 20080051429
    Abstract: Inverse agonists and antagonists of serotonin receptors are disclosed for use in treating sleep disorders such as insomnia, and specifically sleep maintenance insomnia. The compound increase slow wave sleep, decrease the number of awakenings after sleep onset, and decrease the time awake after sleep onset.
    Type: Application
    Filed: April 18, 2007
    Publication date: February 28, 2008
    Inventors: Daniel van Kammen, David Weiner, Mark Brann, Robert Davis